Gaidai reliability method for high-dimensional spatio-temporal biosystems

HIV deathrate prediction by Gaidai multivariate risks assessment method

OBJECTIVES

HIV is a contagious disease with reportedly high transmissibility, being spread worldwide, with certain mortality, allegedly presenting a burden to public health worldwide. The main objective of this study was to determine excessive HIV death risks at any time within any region or country of interest.

STUDY DESIGN

Current study presents a novel multivariate public health system bio-risk assessment approach that is particularly applicable to environmental multi-regional, biological, and public health systems, being observed over a representative period of time, yielding reliable long-term HIV deathrate assessment. Hence, the development of a new bio-statistical approach, that is, population-based, multicenter, and medical survey-based. The expansion of extreme value statistics from the univariate to the bivariate situation meets with numerous challenges. Firstly, the univariate extreme value types theorem cannot be directly extended to the bivariate (2D) case, - not to mention challenges with system dimensionality higher than 2D.

METHODS

Existing bio-statistical methods that process spatiotemporal clinical observations of multinational bio-processes often do not have the advantage of efficiently dealing with high regional dimensionalities and complex nonlinear inter-correlations between different national raw datasets. Hence, this study advocates the direct application of the novel bio-statistical Gaidai method to a raw unfiltered clinical data set.

RESULTS

This investigation described the successful application of a novel bio-risk assessment approach, yielding reliable long-term HIV mortality risk assessments.

CONCLUSIONS

The suggested risk assessment methodology may be utilized in various public bio and public health clinical applications based on available raw patient survey datasets.

Future worldwide coronavirus disease 2019 epidemic predictions by Gaidai multivariate risk evaluation method

Accurate estimation of pandemic likelihood in every US state of interest and at any time. Coronavirus disease 2019 (COVID-19) is an infectious illness with a high potential for global dissemination and low rates of fatality and morbidity, placing some strains on national public health systems. This research intends to benchmark a novel technique, that enables hazard assessment, based on available clinical data, and dynamically observed patient numbers while taking into account pertinent territorial and temporal mapping. Multicentre, population-based, and biostatistical strategies have been utilized to process raw/unfiltered medical survey data. The expansion of extreme value statistics from the univariate to the bivariate situation meets with numerous challenges. First, the univariate extreme value types theorem cannot be directly extended to the bivariate (2D) case,-not to mention challenges with system dimensionality higher than 2D. Assessing outbreak risks of future outbreaks in any nation/region of interest. Existing bio-statistical approaches do not always have the benefits of effectively handling large regional dimensionality and cross-correlation between various regional observations. These methods deal with temporal observations of multi-regional phenomena. Apply contemporary, novel statistical/reliability techniques directly to raw/unfiltered clinical data. The current study outlines a novel bio-system hazard assessment technique that is particularly suited for multi-regional environmental, bio, and public health systems, observed over a representative period. With the use of the Gaidai multivariate hazard assessment approach, epidemic outbreak spatiotemporal risks may be properly assessed. Based on raw/unfiltered clinical survey data, the Gaidai multivariate hazard assessment approach may be applied to a variety of public health applications. The study's primary finding was an assessment of the risks of epidemic outbreaks, along with a matching confidence range. Future global COVID-19/severe acute respiratory syndrome coronavirus 2 (SARS-COV2) epidemic risks have been examined in the current study; however, COVID-19/SARS-COV2 infection transmission mechanisms have not been discussed.